by Jordana Choucair | Nov 4, 2022 | Opioid/Substance Use Disorders
The Centers for Disease Control and Prevention (CDC) released updated guidelines that give clinicians more flexibility in the way they prescribe opioids for short- and long-term pain. The new recommendations avoid strict figures on dosage and length of opioid...
by Jordana Choucair | Nov 4, 2022 | Opioid/Substance Use Disorders
New York Attorney General Letitia James announced that Teva Pharmaceuticals will pay the state up to $523 million to settle claims related to its role in fueling the state’s opioid crisis. The funds are part of Teva’s $4 billion-plus global settlement, which...
by Jordana Choucair | Nov 2, 2022 | Opioid/Substance Use Disorders
CVS, Walgreens, and Walmart have tentatively agreed to pay at least $12 billion to settle a number of lawsuits brought by states and local governments alleging the retailers mishandled prescriptions of opioid painkillers. The deal calls for CVS to pay $5 billion,...
by Jordana Choucair | Oct 28, 2022 | Opioid/Substance Use Disorders
McKinsey & Co agreed to settle claims by hundreds of U.S. local governments and school districts over its role advising opioid manufacturers in their sales of the painkillers which helped fuel the opioid epidemic. The terms of the deal not made public. McKinsey...
by Jordana Choucair | Oct 26, 2022 | Opioid/Substance Use Disorders
An article in Stat explores how terminology used in the field of addiction medicine is out of sync with that of other specialties and impacts the way health professionals view their patients and provide care. Experts point out that using terms such as “alcoholic” or...
by Jordana Choucair | Oct 24, 2022 | Opioid/Substance Use Disorders
Senator Dick Durbin and Representative Lauren Underwood wrote a letter urging the Centers for Medicare & Medicaid Services (CMS) to expand Medicare’s coverage of substance use disorder (SUD) to address key gaps exacerbating the addiction crisis. The lawmakers...
Recent Comments